Probiotics may shield cancer patients from Immunotherapy's gut side effects
NCT ID NCT06508034
First seen Jan 22, 2026 · Last updated May 09, 2026 · Updated 13 times
Summary
This study tests whether taking an over-the-counter probiotic (VSL#3) can prevent colitis (colon inflammation and diarrhea) in cancer patients receiving immunotherapy. About 12 adults with solid tumors who are starting or have just started immunotherapy will take the probiotic daily. The goal is to see if this simple addition can reduce the risk of a common and unpleasant side effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
Conditions
Explore the condition pages connected to this study.